(Q43248376)

17 November 2017

title

Comparative efficacy and safety of amlodipine/benazepril combination therapy and amlodipine monotherapy in severe hypertension (English)

1 reference

17 November 2017

J L Izzo

1

1 reference

17 November 2017

D Purkayastha

series ordinal

2

1 reference

17 November 2017

D Hall

series ordinal

3

1 reference

17 November 2017

R J Hilkert

series ordinal

4

1 reference

17 November 2017

publication date

5 November 2009

1 reference

Journal of Human Hypertension

17 November 2017

published in

1 reference

17 November 2017

volume

24

1 reference

17 November 2017

issue

6

1 reference

17 November 2017

page(s)

403-409

1 reference

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

17 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2009.80

New hypertension guidelines from the National Institute for Health and Clinical Excellence and the British Hypertension Society.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2009.80

The Valsartan Antihypertensive Long-Term Use Evaluation (VALUE) trial: outcomes in patients receiving monotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2009.80

Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2009.80

Initial angiotensin-converting enzyme inhibitor/calcium channel blocker combination therapy achieves superior blood pressure control compared with calcium channel blocker monotherapy in patients with stage 2 hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2009.80

Achieving goal blood pressure in patients with type 2 diabetes: conventional versus fixed-dose combination approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2009.80

Incidence of pedal edema formation with dihydropyridine calcium channel blockers: issues and practical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2009.80

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2009.80

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/JHH.2009.80

1 reference

Dimensions Publication ID

17 November 2017

1015391818

0 references

1 reference